How does fondaparinux work?

Fondaparinux (Arixtra®) differs from standard heparin and LMWH in several ways. In particular, it does not come from animal sources. Instead, this drug is a synthetic version of the active site of the heparin molecule and is an even smaller molecule than LMWH. Heparin blocks both thrombin and factor Xa, whereas LMWH has relatively more activity against factor Xa and relatively less activity against thrombin. By contrast, fondaparinux acts exclusively against factor Xa—it does not affect thrombin. Fondaparinux does not require monitoring.

Current News

Survey: Blood Clot Patients Report Gaps in Education and Support From Doctors

Thank you to the 1,050 blood clot patients who participated in our online survey in May and June of this…

NBCA Presenting at Conference For Women Legislators

The National Blood Clot Alliance (NBCA) is honored to be presenting for the first time at the National Foundation for…